U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
Trastuzumab Imbotolimod
INN  
Official Name English
BDC-1001
Preferred Name English
trastuzumab imbotolimod [INN]
Common Name English
BDC1001
Code English
Immunoglobulin G1 [de-450-lysine], anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal BDC-1001 ?1-chain), disulfide with human-Mus musculus monoclonal BDC-1001 ?-chain, dimer, N6-[33-[4-(4-amino-2-butyl-1H-imidazo[4,5-c]qui
Systematic Name English
BDC 1001 [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
LNG8RG3NMF
Created by admin on Wed Apr 02 05:53:26 GMT 2025 , Edited by admin on Wed Apr 02 05:53:26 GMT 2025
PRIMARY
SMS_ID
300000043802
Created by admin on Wed Apr 02 05:53:26 GMT 2025 , Edited by admin on Wed Apr 02 05:53:26 GMT 2025
PRIMARY
NCI_THESAURUS
C172388
Created by admin on Wed Apr 02 05:53:26 GMT 2025 , Edited by admin on Wed Apr 02 05:53:26 GMT 2025
PRIMARY
INN
12382
Created by admin on Wed Apr 02 05:53:26 GMT 2025 , Edited by admin on Wed Apr 02 05:53:26 GMT 2025
PRIMARY
CAS
2643926-85-4
Created by admin on Wed Apr 02 05:53:26 GMT 2025 , Edited by admin on Wed Apr 02 05:53:26 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966